Rapt Therapeutics Company
Raptis focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
South San Francisco, California, United States
Founded Date:
2015
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Register and Claim Ownership